Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033036 (
APC
)
10,214
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A few aluminophosphate (AlPO) molecular sieves are synthesized hydrothermally under microwave irradiation and conventional electric heating. Less stable AlPO molecular sieves especially with large pore can be obtained preferentially in a short crystallization time because the inter-conversion of less stable phase into a more stable one is prohibited in short reaction time. The VFI transforms into AFI, and finally into
APC
, with the increase of reaction time since the relative stability is VFI < AFI <
APC
under the chosen reaction conditions. The relative stability can be explained with the pore size or by the framework density of each structure. Due to the rapid crystallization involved in the microwave method and instability of porous materials with large pore, these porous materials can be selectively synthesized by microwave irradiation. The synthesis of extra-large-pore
VPI
-5 using triethylamine is also reported for the first time, and the synthesized
VPI
-5 is very stable that can be dried at 100 degrees C at atmospheric pressure without the phase-transformation into AIPO-8.
...
PMID:Phase transformations and phase-selective syntheses of aluminophosphate molecular sieves. 1768 90
Clostridium difficile
is a common cause of health-care acquired diarrhea, resulting in a spectrum of disease from mild diarrhea to life-threatening illness. Sixty
Lactobacillus
strains were screened for anti-
C. difficile
activity using a co-culture method. Based on their ability to inhibit
C. difficile
,
L. gasseri
APC
678 and
L. rhamnosus
DPC 6111 were selected for study in a murine model of
C. difficile
infection.
L. gasseri
ATCC 33323, was included as a control. It was established that, relative to control mice not fed
Lactobacillus
, feeding with
L. gasseri
APC
678 resulted in a significant reduction by day 7 (8-fold,
p
= 0.017) of viable
C. difficile
VPI
10463 in the feces of mice. In contrast, neither
L. rhamnosus
DPC 6111 nor
L. gasseri
ATCC 33323 significantly reduced fecal
C. difficile
shedding. Sequencing of the cecal microbiota showed that in mice fed
L. gasseri
APC
678 there was a significant increase in bacterial diversity across a number of indices when compared to the control or other
Lactobacillus
-fed groups. There was no significant change in the relative abundance of Firmicutes or Bacteroidetes in the group fed
L. gasseri
APC
678 relative to the control, while the groups fed
L. rhamnosus
DPC 6111 or
L. gasseri
ATCC 33323 showed a significant decrease in the relative abundance of Firmicutes (
p
= 0.002 and
p
= 0.019, respectively) and a significant increase in Bacteroidetes (
p
= 0.002 and
p
= 0.023, respectively). These results highlight the potential of
L. gasseri
APC
678 as a live therapeutic agent to target
C. difficile
infection.
...
PMID:
Lactobacillus gasseri
APC 678 Reduces Shedding of the Pathogen
Clostridium difficile
in a Murine Model. 3084 60